IA2030 Scorecard

 — 

Global

  • Type to select a Country

Immunization Agenda 2030 Scorecard

Overview Dashboard

Impact Goal Indicators — Global

The Immunization Agenda 2030’s Framework for Action articulates three Impact Goals for the next decade—Prevent Disease, Promote Equity, and Build Strong Programmes. Global progress toward the Impact Goals will be measured with the seven indicators below, which will serve to mobilize commitment and resources, guide operational planning, and ensure accountability. Click on any indicator to explore its data in more detail.

how to read the charts

Baseline or Comparative Mark

#

2030 Target

On track toward 2030 target

Off track toward 2030 target

Stable or no change

IG1: Prevent Disease
1.1
50 million future deaths averted globally from vaccination delivered by 2030
Cumulative number of deaths averted
Cumulative future deaths averted globally as of 2022 to be on track towards 2030 target 
1.2
All countries achieve the endorsed disease control, elimination and eradication targets
Measles
Rubella
Poliovirus (WPV)
Maternal & Neonatal Tetanus
Countries that have achieved target
1.3
All selected vaccine-preventable diseases have a declining trend in the number of large or disruptive outbreaks
Cholera
Ebola
Measles
Meningococcus
Poliovirus (cVDPV)
Poliovirus (WPV)
Yellow Fever
Number of large or disruptive outbreaks in baseline year
IG2: Promote Equity
2.1
50% reduction in the number of zero dose children
Current progress on zero dose children
Baseline measure of 13.3M as of 2019 
2.2
500 vaccine introductions in low- and middle- income countries
Cumulative vaccine introductions
Cumulative vaccine introductions as of 2022 to be on track towards 2030 target 
IG3: Build Strong Immunization Programs
3.1
90% global coverage for DTP3, MCV2, PCV3, and HPVc
DTP3
PCV3
MCV2
HPVc
Vaccination coverage in baseline year 
3.2
Improve Universal Health Coverage
UHC index in most recent year
Baseline UHC Index of 68

Strategic Priority Indicators — Global

IA2030 is based on a conceptual framework of seven strategic priorities. Each strategic priority has defined goals and objectives and key areas of focus. Action is necessary to achieve these interrelated strategic priorities to realize the overall vision and goals and to ensure that immunization fully contributes to stronger primary health care and attainment of universal health coverage.

how to read the charts

Baseline or Comparative Mark

Positive change since last update

Negative change since last update

No change

SP 1: Immunization Programs for Primary Health Care / Universal Health Coverage
1.1
Proportion of countries with evidence of adopted mechanism for monitoring, evaluation and action at national and subnational levels
Data Not Yet Available
1.2
Density of physicians, nurses and midwives per 10,000 population
1.3
Proportion of countries with on-time reporting from 90% of districts for suspected cases of all priority VPDs included in nationwide surveillance
Data Not Yet Available
1.4
Proportion of time with full availability of DTPcv and MCV at service delivery level
Data Not Yet Available
1.6
Proportion of countries with at least 1 documented individual serious AEFI case safety report per million total population
SP 2: Commitment & Demand
2.1
Proportion of countries with legislation in place that is supportive of immunization as a public good
2.2
Proportion of countries that have implemented behavioural or social strategies to address under-vaccination
SP 3: Coverage & Equity
3.2
Coverage in the 20% of districts with lowest coverage
DTPCV3
MCV1
MCV2
SP 4: Life Course & Integration
4.1
Life course vaccination — breadth of protection
Mean across antigens
SP 5: Outbreaks & Emergencies
5.1
Proportion of outbreaks with timely detection and response
SP 6: Supply & Sustainability
6.1
Level of health of the vaccine market
6.2
Proportion of countries whose domestic government and donor expenditure on primary health care increased or remained stable
6.3
Proportion of countries whose share of national immunization schedule vaccine expenditure funded by domestic government resources increased or remained stable
SP 7: Research & Innovation
7.1
Proportion of countries with an immunization research agenda
7.2
Progress towards global research and development
Data Not Yet Available